Modeling Inflammation on Neurodevelopmental Disorders Using Pluripotent Stem Cells.
Autism spectrum disorders
Congenital Zika syndrome
Disease modeling
Induced pluripotent stem cells (iPSC)
Neurodevelopmental disorders
Neuroinflammation
Journal
Advances in neurobiology
ISSN: 2190-5215
Titre abrégé: Adv Neurobiol
Pays: United States
ID NLM: 101571545
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
25
6
2020
pubmed:
25
6
2020
medline:
11
11
2020
Statut:
ppublish
Résumé
Neurodevelopmental disorders (ND) are characterized by an impairment of the nervous system during its development, with a wide variety of phenotypes based on genetic or environmental cues. There are currently several disorders grouped under ND including intellectual disabilities (ID), attention-deficit hyperactivity disorder (ADHD), and autism spectrum disorders (ASD). Although NDs can have multiple culprits with varied diagnostics, several NDs present an inflammatory component. Taking advantage of induced pluripotent stem cells (iPSC), several disorders were modeled in a dish complementing in vivo data from rodent models or clinical data. Monogenic syndromes displaying ND are more feasible to be modeled using iPSCs also due to the ability to recruit patients and clinical data available. Some of these genetic disorders are Fragile X Syndrome (FXS), Rett Syndrome (RTT), and Down Syndrome (DS). Environmental NDs can be caused by maternal immune activation (MIA), such as the infection with Zika virus during pregnancy known to cause neural damage to the fetus. Our goal in this chapter is to review the advances of using stem cell research in NDs, focusing on the role of neuroinflammation on ASD and environmental NDs studies.
Identifiants
pubmed: 32578148
doi: 10.1007/978-3-030-45493-7_7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM